N-Acetylaspartate and Schizophrenia
Professor Daniel Weinberger discusses the role played by the biochemical N-Acetylaspartate in schizophrenia.
There have been other chemicals that have been measured using neuroimaging techniques. One of the chemicals that weâ€™ve been particularly interested in is a chemical called N-Acetylaspartate which is an amino acid found within nerve cells within neurons in the brain that seems to tell us something about how actively these nerve cells are working. By working, I mean how many synapses they have and how much synaptic activity they have. Synapses are the contacts that nerve cells make with each other and the more contacts a nerve cell has, presumably the more it is involved in the exchange of information, and the more that leads to complex behavior. So, the evidence seems to be that, at least in the hippocampus (an area where thereâ€™s evidence of problems in schizophrenia), the concentrations of N-Acetylaspartate are reduced. Whether this is a primary cause or something that really is going along for the ride because there is a problem there, we donâ€™t know for sure yet.
schizophrenia, chemical, neurochemical, biochemical, brain, hippocampus, daniel, weinberger
Professor Daniel Weinberger explains that dopamine is the major focus of biochemical research into schizophrenia.
Professor Daniel Weinberger explains that the schizophrenia candidate gene, COMT, is abundantly expressed in the hippocampus and prefrontal cortex.
An overview of schizophrenia-related content on Genes to Cognition Online.
Professor Daniel Weinberger discusses evidence that abnormalities in the hippocampus are associated with schizophrenia.
Doctor Daniel Pine makes the important point that the idea of a 'chemical imbalance' as a cause of disorders has pretty much rightfully been given up.
Professor Daniel Weinberger discusses evidence from a number of research areas that highlight the importance of the neurotransmitter glutamate in schizophrenia.
Professor Daniel Weinberger predicts that because of recent progress in genomic research, the future for schizophrenic research is extremely promising.
Professor Daniel Weinberger discusses evidence from a number of areas of research that marks COMT as a candidate gene for schizophrenia.
Professor Daniel Weinberger explains why the gene COMT, which detoxifies dopamine, is a candidate gene for schizophrenia.
Professor Jeffrey Lieberman discusses the dopamine hypothesis, the predominant neurochemical theory of schizophrenia.